Somerville, MA, United States of America

Véronique Darsigny

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novartis Ag. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Véronique Darsigny. Retrieved from https://idiyas.com/inventor/véronique-darsigny

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 22.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Véronique Darsigny

Introduction

Véronique Darsigny is an accomplished inventor based in Somerville, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for medical treatments. His work is characterized by a focus on innovative solutions to complex health issues.

Latest Patents

Darsigny holds a patent for "Hydroquinazoline derivatives for the treatment of a disease or disorder." This patent involves a compound of Formula (I) or a pharmaceutically acceptable salt thereof, where specific components are defined. The patent outlines compositions and methods for utilizing these compounds effectively in medical applications. He has 1 patent to his name.

Career Highlights

Throughout his career, Darsigny has been associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative therapies.

Collaborations

Darsigny has collaborated with notable colleagues such as Daniela Angst and Philippe Bolduc. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Véronique Darsigny is a prominent figure in the field of pharmaceutical innovation. His contributions, particularly in the area of hydroquinazoline derivatives, demonstrate his commitment to advancing medical science. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…